Zimbabwe has declined a significant American healthcare agreement worth 367 million US dollars (272 million pounds) over five years due to Washington's demand for confidential information.
This rejection was revealed after a internal memorandum dated December was disclosed, which showed Head of State Emmerson Mnangagwa felt the deal was "lopsided".
A government spokesman has since clarified that the United States was seeking biological samples for research and profit while was unwilling to share the benefits from any future treatments.
"We are forced to start the difficult and regrettable task of winding down our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the United States had provided more than $1.9bn in health funding to Zimbabwe over the last two decades.
A medical body in Zimbabwe has urged continued talks to find a agreement acceptable to all parties so the nation's critical HIV programme can continue.
Wider Background
This development comes after a comparable situation in Kenya, where a court suspended a similar health funding agreement following legal challenges were raised about the safety of Kenyans' health data.
Since resuming the presidency recently, US President Donald Trump has drastically cut foreign aid and closed the key foreign aid agency.
The agency had managed assistance for the US government, but Trump claimed its expenditure was "wasteful" and his administration was pursuing government-to-government agreements to boost openness and accountability.
According to reports, Sixteen African countries have so far signed similar agreements, representing more than $18.3bn in committed funds.
Details of the Rejected Deal
The money for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this cooperation could have provided significant benefits for Zimbabwean communities, particularly the 1.2 million presently receiving HIV treatment via American-funded initiatives," Tremont added.
However, government spokesperson Nick Mangwana argued the arrangement was "unequal".
"Our nation was requested to share its biological resources and data over an extended period, with no corresponding guarantee of access to any medical innovations – such as new medicines or tests – that might be developed from that provided information," his statement read.
"In essence, our country would supply the basic resources for medical research without any certainty that the resulting innovations would be accessible to our population should a future health crisis emerge."
National Interest and International Frameworks
Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were disrupting structures previously set up through the international health agency.
The spokesperson cited its Pandemic Benefit-Sharing system created to manage future pandemics.
"This framework is designed to ensure that when a country contributes its data, the benefits – including medicines and cures – are shared equitably, not monopolised solely by those with the funds to develop them."
These objections regarding the US deal "are not meant as hostility towards the US," he added.
"We welcome continued dialogue with our US partners on how subsequent co-operation could be designed in a way that honours the independence and interests of both nations."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the official position, but recommended that talks should continue considering much of the nation's Aids initiatives were funded by external financing.
"Where technical issues exist, such as those relating to data governance or agreement terms, these can often be addressed through detailed discussion and negotiated safeguards," it added.
The halted deal emphasises the complex tensions between receiving much-needed foreign assistance and protecting a country's data in an increasingly interconnected world.